))
10/24/25 AM UPDATE: Lilly taking weight-loss drug to India; Tanco Terminals expanding in Jeffersonville; H-1B visa fees causing confusion
Manage episode 515361882 series 3513429
محتوای ارائه شده توسط IBJ Media. تمام محتوای پادکست شامل قسمت‌ها، گرافیک‌ها و توضیحات پادکست مستقیماً توسط IBJ Media یا شریک پلتفرم پادکست آن‌ها آپلود و ارائه می‌شوند. اگر فکر می‌کنید شخصی بدون اجازه شما از اثر دارای حق نسخه‌برداری شما استفاده می‌کند، می‌توانید روندی که در اینجا شرح داده شده است را دنبال کنید.https://fa.player.fm/legal
Inside INdiana Business Radio for the morning of Oct. 24, 2025. Eli Lilly and Co. has entered into an agreement with India-based drugmaker Cipla to sell its blockbuster weight-loss drug, tirzepatide, under a different brand name. Portage-based Tanco Terminals has announced a $750,000 expansion of its liquid barge facility at the Ports of Indiana-Jeffersonville. President Trump's recently announced $100,000 annual fee on new H-1B visas is causing confusion for businesses and the attorneys that represent them. Plus, a Bloomington-based biotechnology startup takes the top prize at a national pitch competition inspired by the creator of Gatorade.
Get the latest business news from throughout the state at InsideINdianaBusiness.com.
1750 قسمت
اشتراک گذاری
